Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2007 1
2008 3
2009 1
2010 1
2012 4
2013 1
2014 3
2015 5
2016 1
2017 1
2018 1
2019 1
2020 4
2021 5
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
Formate overflow drives toxic folate trapping in MTHFD1 inhibited cancer cells.
Green AC, Marttila P, Kiweler N, Chalkiadaki C, Wiita E, Cookson V, Lesur A, Eiden K, Bernardin F, Vallin KSA, Borhade S, Long M, Ghahe EK, Jiménez-Alonso JJ, Jemth AS, Loseva O, Mortusewicz O, Meyers M, Viry E, Johansson AI, Hodek O, Homan E, Bonagas N, Ramos L, Sandberg L, Frödin M, Moussay E, Slipicevic A, Letellier E, Paggetti J, Sørensen CS, Helleday T, Henriksson M, Meiser J. Green AC, et al. Among authors: slipicevic a. Nat Metab. 2023 Apr;5(4):642-659. doi: 10.1038/s42255-023-00771-5. Epub 2023 Apr 3. Nat Metab. 2023. PMID: 37012496 Free PMC article.
Narrowing the knowledge gaps for melanoma.
Slipicevic A, Herlyn M. Slipicevic A, et al. Ups J Med Sci. 2012 May;117(2):237-43. doi: 10.3109/03009734.2012.658977. Epub 2012 Feb 16. Ups J Med Sci. 2012. PMID: 22339359 Free PMC article. Review.
KIT in melanoma: many shades of gray.
Slipicevic A, Herlyn M. Slipicevic A, et al. J Invest Dermatol. 2015 Feb;135(2):337-338. doi: 10.1038/jid.2014.417. J Invest Dermatol. 2015. PMID: 25573046 Free PMC article.
Targeting aggressive osteosarcoma with a peptidase-enhanced cytotoxic melphalan flufenamide.
Byrgazov K, Anderson C, Salzer B, Bozsaky E, Larsson R, Gullbo J, Lehner M, Lehmann F, Slipicevic A, Kager L, Fryknäs M, Taschner-Mandl S. Byrgazov K, et al. Among authors: slipicevic a. Ther Adv Med Oncol. 2020 Jul 29;12:1758835920937891. doi: 10.1177/1758835920937891. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32774473 Free PMC article.
MX 2 is a novel regulator of cell cycle in melanoma cells.
Juraleviciute M, Pozniak J, Nsengimana J, Harland M, Randerson-Moor J, Wernhoff P, Bassarova A, Øy GF, Trøen G, Flørenes VA, Bishop DT, Herlyn M, Newton-Bishop J, Slipicevic A. Juraleviciute M, et al. Among authors: slipicevic a. Pigment Cell Melanoma Res. 2020 May;33(3):446-457. doi: 10.1111/pcmr.12837. Epub 2019 Nov 13. Pigment Cell Melanoma Res. 2020. PMID: 31660681 Free PMC article.
Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen.
Gebraad A, Ohlsbom R, Miettinen JJ, Emeh P, Pakarinen TK, Manninen M, Eskelinen A, Kuismanen K, Slipicevic A, Lehmann F, Nupponen NN, Heckman CA, Miettinen S. Gebraad A, et al. Among authors: slipicevic a. Cells. 2022 May 7;11(9):1574. doi: 10.3390/cells11091574. Cells. 2022. PMID: 35563880 Free PMC article.
Pax-5 expression in nonhematopoietic tissues.
Torlakovic E, Slipicevic A, Robinson C, DeCoteau JF, Alfsen GC, Vyberg M, Chibbar R, Flørenes VA. Torlakovic E, et al. Among authors: slipicevic a. Am J Clin Pathol. 2006 Nov;126(5):798-804. doi: 10.1309/XEC7-JMW9-YRM7-4RNO. Am J Clin Pathol. 2006. PMID: 17050077
34 results